A Form 144 notice of proposed sale was filed on November 18, 2026, by The Keith and Priscilla Gaesli U/A DTD 08/13/2010, a trust associated with a director of Synaptics Incorporated, disclosing plans to sell 7,933 shares of common stock through Morgan Stanley Smith Barney LLC.
Key Highlights
- Seller: The Keith and Priscilla Gaesli U/A DTD 08/13/2010, identified as a Director-related account of Synaptics Incorporated
- Shares proposed for sale: 7,933 shares of Synaptics common stock
- Aggregate market value: $931,121.17 as stated in the filing
- Approximate date of sale: November 18, 2026, on the NASDAQ exchange
- Shares outstanding: 39,728,516 shares of common stock reported outstanding
- Broker named: Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004
- No sales in past 3 months: The filing reports nothing to disclose for securities sold during the prior three months
Proposed Sale Details and Acquisition History for Synaptics Director Trust
According to the filing, The Keith and Priscilla Gaesli U/A DTD 08/13/2010, a trust with a director relationship to Synaptics Incorporated (NASDAQ:SYNA), submitted a Form 144 notice proposing to sell 7,933 shares of Synaptics common stock. The filing lists an aggregate market value of $931,121.17 for the proposed sale and identifies NASDAQ as the exchange on which the sale is to be executed. The notice was signed by /s/ Keith Bewley Geeslin.
The filing details nine separate acquisition lots underlying the shares to be sold. These include restricted stock grants received from the issuer on various dates: 541 shares acquired February 1, 2023; 280 shares on August 1, 2022; 280 shares on May 1, 2022; 280 shares on February 1, 2022; 617 shares on April 30, 2021; 617 shares on July 31, 2021; and 616 shares on October 31, 2021. Additionally, two lots were acquired via exercised shares: 2,302 shares on August 11, 2022, with cash payment, and 2,400 shares on June 10, 2021, with cash payment. All restricted stock acquisitions are listed with "Not Applicable" for nature of payment.
The filing states that no securities of the issuer were sold during the past three months by the person for whose account the securities are to be sold, reporting "Nothing to Report" in that section. The notice includes the standard Rule 144 representation that the signer does not know of any material adverse information regarding the current and prospective operations of Synaptics that has not been publicly disclosed.
What Was Disclosed
A Form 144 filing by a Synaptics director-affiliated trust proposed the sale of 7,933 common shares valued at $931,121.17 through Morgan Stanley Smith Barney LLC, with an approximate sale date of November 18, 2026, on NASDAQ. No prior three-month sales were reported.



Please wait processing your request...